KAS
Kestra Advisory Services Portfolio holdings
AUM
$20.5B
1-Year Return
20.08%
This Quarter Return
-13.64%
1 Year Return
+20.08%
3 Year Return
+68.73%
5 Year Return
+108.99%
10 Year Return
–
AUM
$9.73B
AUM Growth
+$129M
(+1.3%)
Cap. Flow
+$1.57B
Cap. Flow
% of AUM
16.09%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
2,274
New
276
Increased
1,266
Reduced
546
Closed
146
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$150M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$89.2M |
| 3 |
Vanguard Value ETF
VTV
|
$39.3M |
| 4 |
Vanguard Growth ETF
VUG
|
$34.8M |
| 5 |
Apple
AAPL
|
$34.6M |
Top Sells
Sector Composition
| 1 | Technology | 9.44% |
| 2 | Financials | 5.42% |
| 3 | Healthcare | 5.27% |
| 4 | Communication Services | 5.17% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Vuzix
VUZI
$188M
| $87K | ﹤0.01% |
12,256
+2,037
| +20% | +$14.5K |
|
2002
Clean Energy Fuels
CLNE
$546M
| $85K | ﹤0.01% |
+18,980
| New | +$85K |
|
2003
Amneal Pharmaceuticals
AMRX
$3.02B
| $84K | ﹤0.01% |
26,486
+814
| +3% | +$2.58K |
|
2004
Nine Energy Service
NINE
$28.5M
| $80K | ﹤0.01% |
30,356
| – | – |
|
|
FAM
2005
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
| $80K | ﹤0.01% |
13,186
-8,089
| -38% | -$49.1K |
|
|
JNCE
2006
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $80K | ﹤0.01% |
26,250
+800
| +3% | +$2.44K |
|
|
FTF
2007
Franklin Limited Duration Income Trust
FTF
$260M
| $79K | ﹤0.01% |
11,714
+722
| +7% | +$4.87K |
|
2008
US Global Investors
GROW
$31.8M
| $79K | ﹤0.01% |
+17,822
| New | +$79K |
|
2009
Nuveen Credit Strategies Income Fund
JQC
$746M
| $77K | ﹤0.01% |
+14,764
| New | +$77K |
|
2010
Marathon Digital Holdings
MARA
$5.63B
| $76K | ﹤0.01% |
14,291
-4,830
| -25% | -$25.7K |
|
2011
Archer Aviation
ACHR
$5.48B
| $75K | ﹤0.01% |
24,450
+3,950
| +19% | +$12.1K |
|
|
AVDL
2012
Avadel Pharmaceuticals
AVDL
$1.53B
| $74K | ﹤0.01% |
30,400
-16,150
| -35% | -$39.3K |
|
2013
Aldeyra Therapeutics
ALDX
$334M
| $72K | ﹤0.01% |
17,938
| – | – |
|
2014
BlackRock Enhanced International Dividend Trust
BGY
$534M
| $72K | ﹤0.01% |
+14,322
| New | +$72K |
|
2015
Denison Mines
DNN
$2.11B
| $72K | ﹤0.01% |
73,871
+24,000
| +48% | +$23.4K |
|
|
AMRN
2016
Amarin Corp
AMRN
$311M
| $71K | ﹤0.01% |
2,380
+189
| +9% | +$5.64K |
|
2017
Coeur Mining
CDE
$9.43B
| $71K | ﹤0.01% |
+23,491
| New | +$71K |
|
2018
Sabre
SABR
$675M
| $71K | ﹤0.01% |
12,096
+131
| +1% | +$769 |
|
2019
BlackBerry
BB
$2.31B
| $70K | ﹤0.01% |
+12,918
| New | +$70K |
|
2020
ADT
ADT
$7.13B
| $68K | ﹤0.01% |
+11,076
| New | +$68K |
|
2021
Playboy, Inc. Common Stock
PLBY
$187M
| $66K | ﹤0.01% |
+10,368
| New | +$66K |
|
2022
Citius Pharmaceuticals
CTXR
$20.9M
| $65K | ﹤0.01% |
2,844
+1,239
| +77% | +$28.3K |
|
2023
Cemex
CX
$13.6B
| $63K | ﹤0.01% |
+16,115
| New | +$63K |
|
2024
Ambev
ABEV
$34.8B
| $61K | ﹤0.01% |
24,283
+3,215
| +15% | +$8.08K |
|
2025
Inseego
INSG
$199M
| $61K | ﹤0.01% |
3,232
-176
| -5% | -$3.32K |
|